Latest News about Briefs
Recent news which mentions Briefs
European Commission Declines To Renew Marketing Authorization Of Translarna Duchenne Muscular Disorder
March 28, 2025
From Benzinga
Why Is Milestone Pharmaceuticals Stock Plunging Today?
March 28, 2025
From Benzinga
Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors
March 28, 2025
From Benzinga
From Benzinga
From Benzinga
W. R. Berkley Stock Soars After Mitsui Sumitomo Investment Signals Long-Term Growth Alignment
March 28, 2025
From Benzinga
From Benzinga
Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk
March 28, 2025
From Benzinga
European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps
March 28, 2025
From Benzinga
Enlight Wins Major Tender To Build Green Data Center In Israel, Plans To Invest Up To $1.1 Billion
March 28, 2025
From Benzinga
Assassin's Creed Maker Ubisoft's Gaming Subsidiary Secures $1.25 Billion Tencent Backing In Major Deal
March 28, 2025
From Benzinga
From Benzinga
Lockheed Martin And Google Partner To Advance AI In Defense
March 28, 2025
From Benzinga
Asia Markets Mixed, Europe Falls On Auto Tariff Concerns And Gold Hits All-Time High - Global Markets Today While US Slept
March 28, 2025
From Benzinga
From Benzinga
JP Morgan's Top Video Game Stocks Of 2025
March 27, 2025
From Benzinga
Microsoft Plans Proprietary AI To Power Business Software And Reduce OpenAI Dependence: Report
March 27, 2025
From Benzinga
Candel Therapeutics Reports Prolonged Survival In Mid-Stage Study For Pretreated Lung Cancer Patients
March 27, 2025
From Benzinga
Atmus Filtration's Path To Growth: Analyst Highlights Strong Financials, Tariff Pricing Power
March 27, 2025
From Benzinga
Ultragenyx Stays On JPMorgan's Focus List As Analyst Highlights Strong Long-Term Positioning
March 27, 2025
From Benzinga
From Benzinga
Chemomab Therapeutics' Touts Positive Data From Experimental Drug For Chronic Liver Disease
March 27, 2025
From Benzinga
From Benzinga
Goldman Sachs Sees More Upside In Real Estate Data As February Volumes Surge And Revisions Trend Higher
March 27, 2025
From Benzinga
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
March 27, 2025
From Benzinga
From Benzinga
Liberty Energy Earns Bullish Call From Morgan Stanley As Data Center Demand, PGS Upside Gain Traction
March 27, 2025
From Benzinga
Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancer
March 27, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.